Alendronate improves QOL of postmenopausal women with osteoporosis

PURPOSE: Postmenopausal osteoporosis causes bone fracture as well as pain, physical, psychological and socially adverse effects, which affects a patient’s quality of life (QOL). The effect of alendronate on QOL was investigated compared with that of alfacalcidol in post-menopausal osteoporotic women...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kawate, Hisaya, Ohnaka, Keizo, Adachi, Masahiro, Kono, Suminori, Ikematsu, Hideyuki, Matsuo, Hisashi, Higuchi, Kazumi, Takayama, Takehiko, Takayanagi, Ryoichi
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove Medical Press 2010
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861847/
https://ncbi.nlm.nih.gov/pubmed/20458350
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים